Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Hyaluronan digestion controls DC migration from the skin
Jun Muto, … , Ajit Varki, Richard L. Gallo
Jun Muto, … , Ajit Varki, Richard L. Gallo
Published February 3, 2014
Citation Information: J Clin Invest. 2014;124(3):1309-1319. https://doi.org/10.1172/JCI67947.
View: Text | PDF
Research Article Immunology

Hyaluronan digestion controls DC migration from the skin

  • Text
  • PDF
Abstract

The breakdown and release of hyaluronan (HA) from the extracellular matrix has been hypothesized to act as an endogenous signal of injury. To test this hypothesis, we generated mice that conditionally overexpressed human hyaluronidase 1 (HYAL1). Mice expressing HYAL1 in skin either during early development or by inducible transient expression exhibited extensive HA degradation, yet displayed no evidence of spontaneous inflammation. Further, HYAL1 expression activated migration and promoted loss of DCs from the skin. We subsequently determined that induction of HYAL1 expression prior to topical antigen application resulted in a lack of an antigenic response due to the depletion of DCs from the skin. In contrast, induction of HYAL1 expression concurrent with antigen exposure accelerated allergic sensitization. Administration of HA tetrasaccharides, before or simultaneously with antigen application, recapitulated phenotypes observed in HYAL1-expressing animals, suggesting that the generation of small HA fragments, rather than the loss of large HA molecules, promotes DC migration and subsequent modification of allergic responses. Furthermore, mice lacking TLR4 did not exhibit HA-associated phenotypes, indicating that TLR4 mediates these responses. This study provides direct evidence that HA breakdown controls the capacity of the skin to present antigen. These events may influence DC function in injury or disease and have potential to be exploited therapeutically for modification of allergic responses.

Authors

Jun Muto, Yasuhide Morioka, Kenshi Yamasaki, Margaret Kim, Andrea Garcia, Aaron F. Carlin, Ajit Varki, Richard L. Gallo

×

Figure 3

Decreased DC number in the epidermis of K14CreERT/HYAL1 mice after tamoxifen application.

Options: View larger image (or click on image) Download as PowerPoint
Decreased DC number in the epidermis of K14CreERT/HYAL1 mice after tamox...
(A) DCs per mm2 were determined by counting MHC class II immunostained cells in 8 different microscopic fields of the epidermal sheets 0, 24, 48, and 72 hours after topical tamoxifen application. Mean and SEM are shown on the graph (n = 4). (B) 0, 24, 48, 72 hours after tamoxifen treatment, epidermal sheets were harvested and stained with MHC class II antibody. Scale bar: 50 μm. (C) 48 hours after tamoxifen treatment, epidermal sheets were stained with CD80 antibody. Scale bar: 50 μm. (D) Increased trafficking of skin DCs in tamoxifen-dependent HYAL1-overexpressing transgenic mice. Representative plots of eFluor670 fluorescence plotted against CD11c from DLNs of transgenic mice 24 hours after painting eFluor670 dissolved in acetone on shaved and tamoxifen- or vehicle-treated abdominal skin. (E) Number of CD11c+eFluor670+ DCs in DLNs of tamoxifen-dependent HYAL1-overexpressing mice (K14CreERT/HYAL1, black bar) compared with vehicle-treated control mice (K14CreERT/HYAL1, gray bar) (n = 4). (F) Representative dot plots of CD11c against side scatter from DLNs of transgenic mice 72 hours after tamoxifen or vehicle treatment on abdominal skin. (G) Percentage of CD11c+ DCs in DLNs of tamoxifen-dependent HYAL1-overexpressing mice (K14CreERT/HYAL1, black bar) compared with vehicle-treated control mice (K14CreERT/HYAL1, gray bar) (n = 4). Mean and SEM are shown on the graph. Data are representative of 2 separate experiments with similar results. *P < 0.05, ***P < 0.001.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts